Extended suboxone use reduces withdrawal effects

Categories

Addiction Treatment
Alcohol
Drugs
Gambling
In the papers
On TV

News Archive

Home » News » Drugs » Extended suboxone use reduces withdrawal effects

by Change | 27 Nov 2008

Bookmark

E-mail

New drug trials suggest an extended use of suboxone all can reduce withdrawal effects and decrease the chances of relapse.

Clinical trials have suggested a longer programme of use for an existing medication gives those undergoing drug rehab programmes a higher chance of success.

Research published in the Journal of the American Medical Association reveals longer use of suboxone on those with opiate addictions gives them a better chance of success than short-term detoxification.

Conducted by the National drug abuse treatment Clinical Trials Network, in conjunction with the National Institute on Drug Abuse, the study suggests the chemical might allow more effective morphine, oxycontin and heroin treatment.

Young people with drug addictions who took the substance for a period of 12 weeks - as opposed to the standard two - were less likely to relapse.

Dr George Woody, principal investigator at the University of Pennsylvania, claims it effectively controls withdrawal symptoms.

"The teens and young adults readily accepted suboxone and tolerated it well. They seldom complained about [side effects] and were pleased that they remained alert and could function during the day," he states.

In recent scientific studies, vigabatrin appeared to reduce the risk of relapse for those with methamphetamine addictions.

Conducted by the Brookhaven National Laboratory and published in Synapse, the medication is believed to block the behaviours associated with reversion.

Bookmark this: